Benchmark Reiterates Speculative Buy Rating on Intensity Therapeutics, Inc. (INTS)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall St set for lower open as Alphabet results reignite AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| (NASDAQ: INTS) | Delayed: 3.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.38 | 52 Week High | $ | |||
| Open | $3.38 | 52 Week Low | $ | |||
| Day High | $3.38 | P/E | N/A | |||
| Day Low | $3.38 | EPS | $ | |||
| Volume | 1 | |||||
